Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Bio Technology General - BTGC -- Ignore unavailable to you. Want to Upgrade?

To: Michael G. Potter who wrote (1876)	7/13/1999 12:35:00 PM
From: Bosco	Read Replies (2) \| Respond to of 2028

G'day all - yes, I agree jubilation is a bit premature [no pun intended.] However, if the application can be proven to be of high utility in a more thorough Phase II trial, my guess is that there is a good chance of gaining fast track status. Premies may not be as appealing as dragged diseases like terminal cancers or AIDS etc, but a heart wrenching life experience nonetheless. Of course, if additional Phase II demonstrates high efficacy, BTGC stock will probably move ahead of itself. best, Bosco